Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
10/24/14 Rhythm Pharmaceuticals Relamorelin for Chronic Idiopathic Constipation Subscribers Only Subscribers Only Subscribers Only
10/24/14 Verastem, Inc. (VSTM) VS-6063 for Mesothelioma Subscribers Only Subscribers Only Subscribers Only
10/23/14 Baxter (BAX) Obizur for Acquired Hemophilia Subscribers Only Subscribers Only Subscribers Only
10/23/14 Pfizer (PFE) Duavee for Menopause (including Hormone Replacement Therapy [HRT]) Subscribers Only Subscribers Only Subscribers Only
10/23/14 AstraZeneca (AZN) Lynparza for Ovarian Cancer Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
Now - 10/26/14 Subscribers Only Subscribers Only Trial Data - Updated Results
10/26/14 Subscribers Only Subscribers Only Patent - Expiration of 30-Month Stay
10/26/14 Subscribers Only Subscribers Only Trial Data - Other
Now - 10/27/14 Subscribers Only Subscribers Only Regulatory - Orphan Drug Designation (U.S.)
10/27/14 Subscribers Only Subscribers Only Company - Earnings Announcement